Colour enhancement

From PsychonautWiki
Jump to navigation Jump to search

Colour enhancement is defined as an intensification of the brightness and vividness of colors in the external environment. During this experience, reds may seem “redder”, greens may seem “greener", and all colors will likely appear much more distinct, complex, and visually intense than they comparatively would be during everyday sober living.[1][2][3][4][5][6][7][8] At higher levels, this effect can sometimes result in seeing colours which are perceived as surreal or seemingly impossible.[3][4]

Colour enhancement is often accompanied by other coinciding effects such as acuity enhancement and pattern recognition enhancement.[1][2] It is most commonly induced under the influence of mild dosages of psychedelic compounds, such as LSD, psilocybin, and mescaline. However, it can also occur to a lesser extent under the influence of certain stimulants and dissociatives such as MDMA, ketamine[9], or 3-MeO-PCP.

Image examples

 Caption
Mescaline
DMT
DOI
4-AcO-DiPT
Paradise island by Xanny.jpgParadise island by Subsentience
Experience:4.5g - The Grand Introduction to Beauty and Fear
Methallylescaline
Enhancement of colours - woods.jpgThe Woods by Chelsea Morgan
Experience:25mg 3-MeO-PCP - Enhanced film experience
2C-P
ALD-52
DOM
5-Hydroxytryptophan
Experience:BK-2C-B - Various experiences
Experience:225ug LSD + 9g cubensis - Galactic Melt and the Meverse
25B-NBOH
Experience:4-HO-MiPT / A care free psychedelic getaway
MPT
EPT
4-HO-MPT
DOB
Psilocin
Pregabalin
4-HO-DPT
Aniracetam
JWH-018
Efavirenz
PRO-LAD
4-HO-DiPT
4-AcO-DET
25C-NBOMe
2C-T-2
Experience:250mg DXM - DXM Itch and Trip Report
25I-NBOMe
Experience:1mg 25c-NBOMe - Experiment in my room
LSM-775
2C-T-7
5-MeO-DALT
TMA-2
LSA
Experience:3-MeO-PCP - Extreme psychosis
3-MMC
GABAergic hallucinogens
Cannabis
LSD
Experience:4-AcO-DMT + 200mg Pill
Allylescaline
1P-ETH-LAD
Chameleon.jpgChameleon by Anonymous.
25B-NBOMe
Piracetam
4-HO-MET
6-APDB
DPT
2C-B
25I-NBOH
4-FA
6-APB
MiPT
Experience:Unknown dosage / 1 tab DOC - Psychedelia Turned Into Stimulant Psychosis
Tree.jpgJapanese Garden by Anonymous
Bromo-DragonFLY
Experience:4x 200ug tabs - You do not need to understand
Experience:75mg 3-FMA - Perfect Blend of Euphoria and Functionality
Experience:3.5g psilocybe cubensis - Relinquishing of Material Chains/Fear and Desolation
4-AcO-MiPT
4-HO-MiPT
Coluracetam
DOC
Amanita muscaria
MDAI
Escaline
Experience:2.5g Syrian rue + 6g Mimosa Hostilis - Becoming God (my second experience with unity)
Experience:337mg DMT fumarate - A Day With DMT
4-HO-DET
Experience:A combination of DOC, 5-MAPB, 5-MeO-DMT, ETH-LAD, Cannabis, Pentedrone
Phenethylamine (compound)
3-MeO-PCE
Pramiracetam
MET
25D-NBOMe
Experience:225mg Pregabalin +Cannabis -Bliss and Serenity; a hedonistic evening
1B-LSD
MiPLA
Experience:60mg 4-AcO-DMT Nonstop Quasi-Orgasmic Objectless Euphoria
4-HO-EPT
5-MeO-MiPT
25C-NBOH
2C-H
Experience:Mushrooms and Snuff Films -- Trip Report (3.5 grams)
5-MeO-DiBF
Experience: 36mg 4-AcO-DiPT - Truly, one for the psychedelic animals among us
Proscaline
Experience:3 Grams of Mushrooms - Reset on my Life, Experiencing Satori and the Cosmic Perspective
Enhancement of colour rose.jpgRose by Chelsea Morgan
LSZ
2C-B-FLY
MDMA
5-MeO-DiPT
Experience:150mg MDMA + 20mg 2C-B - I designed it this way myself
Experience: 22mg 2C-B (oral) / 100ug 1P-LSD (sublingual) - My first time tripping alone (2 days in a row)
4-AcO-MET
Experience:Unknown Dose DOC (Insufflated) - Overdosing and Terifying Ego Death
PARGY-LAD
Psilocybin mushrooms
TMA-6
Βk-2C-B
Omberacetam
Chur City in Switzerland.jpgChur, Switzerland by Naps284
Ibogaine
DiPT
DET
Experience:120mg - Garden of The Gods
Experience:2C-P (approx. 35mg) - Asymmetrical Terror and the Geometric Sea
1P-LSD
Selective serotonin reuptake inhibitor
Enhancementofcolour.jpgShowing differences by Chelsea Morgan
THJ-018
Experience:25mg Deschloroketamine - My first time orally dosing DCK
2C-T-21
Bufotenin
Experience:800 seeds LSA - My First Trip Ever
Experience:300µg LSD - Togetherness and the Silent Dusk
4-AcO-DMT
Experience:5.3g psilocybe cubensis - Dimensional Circumstance and the Fabric of Understanding
3C-E
Memantine
MDA
5F-PB-22
Ayahuasca
JWH-073
Experience: 15mg 2C-B (oral) - A pleasant low-dose evening with Nexus
2C-D
ΑMT
MDEA
Experience:1000 Morning Glory seeds - Rediscovering the Self
THJ-2201
Experience:300mg DXM + 25mg DMT + Cannabis - A crazy night
AL-LAD
Phenylpiracetam
2C-I
Experience:2 tabs DOB - My DOB Nightmare
Experience: 5-EAPB (60mg) + 2-FMA (20mg) + 4-AcO-DMT (10mg) - Emotional catharsis
Experience:3g mimosa / 3g syrian rue - Connecting with my body
Oxiracetam
2C-C
25N-NBOMe
Experience:40mg - Brothermind and the Forest's Hand
2C-E
ETH-LAD
Experience:300µg AL-LAD - Don't worry, because you're everyone!

Psychoactive substances

Compounds within our psychoactive substance index which may cause this effect include:

... further results

Experience reports

Annectdotal reports which describe this effect with our experience index include:

See also

External links

References

  1. 1.0 1.1 Papoutsis, Ioannis; Nikolaou, Panagiota; Stefanidou, Maria; Spiliopoulou, Chara; Athanaselis, Sotiris (2014). "25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers". Forensic Toxicology. 33 (1): 1–11. doi:10.1007/s11419-014-0242-9. ISSN 1860-8965. 
  2. 2.0 2.1 Bersani, Francesco Saverio; Corazza, Ornella; Albano, Gabriella; Valeriani, Giuseppe; Santacroce, Rita; Bolzan Mariotti Posocco, Flaminia; Cinosi, Eduardo; Simonato, Pierluigi; Martinotti, Giovanni; Bersani, Giuseppe; Schifano, Fabrizio (2014). "25C-NBOMe: Preliminary Data on Pharmacology, Psychoactive Effects, and Toxicity of a New Potent and Dangerous Hallucinogenic Drug". BioMed Research International. 2014: 1–6. doi:10.1155/2014/734749. ISSN 2314-6133. 
  3. 3.0 3.1 Hartman, Alan M.; Hollister, Leo E. (1963). "Effect of mescaline, lysergic acid diethylamide and psilocybin on color perception". Psychopharmacologia. 4 (6): 441–451. doi:10.1007/BF00403349. ISSN 0033-3158. 
  4. 4.0 4.1 Kleinman, J. E.; Gillin, J. C.; Wyatt, R. J. (1977). "A Comparison of the Phenomenology of Hallucinogens and Schizophrenia From Some Autobiographical Accounts*". Schizophrenia Bulletin. 3 (4): 560–586. doi:10.1093/schbul/3.4.560. ISSN 0586-7614. 
  5. . doi:10.3389/Ffnhum.2015.00346.  Missing or empty |title= (help)
  6. Obreshkova, D., Kandilarov, I., Angelova, V. T., Iliev, Y., Atanasov, P., & Fotev, P. S. (2017). PHARMACO-TOXICOLOGICAL ASPECTS AND ANALYSIS OF PHENYLALKYLAMINE AND INDOLYLALKYLAMINE HALLUCINOGENS (REVIEW). PHARMACIA, 64(1), 41-42. http://bsphs.org/wp-content/uploads/2017/04/Angelova.pdf
  7. Abraham, Henry David (1983). "Visual Phenomenology of the LSD Flashback". Archives of General Psychiatry. 40 (8): 884. doi:10.1001/archpsyc.1983.01790070074009. ISSN 0003-990X. 
  8. Baggott, M.J.; Coyle, J.R.; Erowid, E.; Erowid, F.; Robertson, L.C. (2011). "Abnormal visual experiences in individuals with histories of hallucinogen use: A web-based questionnaire". Drug and Alcohol Dependence. 114 (1): 61–67. doi:10.1016/j.drugalcdep.2010.09.006. ISSN 0376-8716. 
  9. Dillon, P (2003). "Patterns of use and harms associated with non-medical ketamine use". Drug and Alcohol Dependence. 69 (1): 23–28. doi:10.1016/S0376-8716(02)00243-0. ISSN 0376-8716.